Skip to main content
Top
Published in: BMC Oral Health 1/2021

Open Access 01-12-2021 | Oral and Maxillofacial Surgery | Research article

Effect of educational intervention on the appropriate use of oral antimicrobials in oral and maxillofacial surgery: a retrospective secondary data analysis

Authors: Junya Kusumoto, Atsushi Uda, Takeshi Kimura, Shungo Furudoi, Ryosuke Yoshii, Megumi Matsumura, Takayuki Miyara, Masaya Akashi

Published in: BMC Oral Health | Issue 1/2021

Login to get access

Abstract

Background

In Japan, oral third-generation cephalosporins with broad-spectrum activity are commonly prescribed in the practices of dentistry and oral surgery. However, there are few reports on the appropriate use of antibiotics in the field of oral surgery. This study aimed to evaluate the appropriateness of antibiotic use before and after an educational intervention in the Department of Oral and Maxillofacial Surgery, Kobe University Hospital.

Methods

The use of oral antibiotics was investigated among inpatients and outpatients before and after an educational intervention conducted by the antimicrobial stewardship team. Additionally, the frequency of surgical site infection after the surgical removal of an impacted third mandibular molar under general anesthesia and the prevalence of adverse effects of the prescribed antibiotics were comparatively evaluated between 2013 and 2018.

Results

After the educational intervention, a remarkable reduction was noted in the prescription of oral third-generation cephalosporins, but increased use of penicillins was noted among outpatients. There was reduced use of macrolides and quinolones in outpatients. Although a similar trend was seen for inpatients, the use of quinolones increased in this population. Despite the change in the pattern of antibiotic prescription, inpatients who underwent mandibular third molar extraction between 2013 and 2018 did not show a significant increase in the prevalence of surgical site infections (6.2% vs. 1.8%, p = .336) and adverse effects of drugs (2.1% vs. 0%, p = .466).

Conclusions

This study suggests that the judicious use of oral antibiotics is possible through conscious and habitual practice of appropriate antibiotic use. However, further investigation is required to develop measures for appropriate use of oral antibiotics.
Appendix
Available only for authorised users
Literature
2.
go back to reference Weiner LM, Fridkin SK, Apontes-Torres Z, Avery L, Coffin N, Dudeck MA, et al. Vital signs: preventing antibiotic-resistant infections in hospitals-United States, 2014. Morb Mortal Wkly Rep. 2016;65:235–41.CrossRef Weiner LM, Fridkin SK, Apontes-Torres Z, Avery L, Coffin N, Dudeck MA, et al. Vital signs: preventing antibiotic-resistant infections in hospitals-United States, 2014. Morb Mortal Wkly Rep. 2016;65:235–41.CrossRef
4.
go back to reference World Health Organization. Global action plan on antimicrobial resistance. 2015. World Health Organization. Global action plan on antimicrobial resistance. 2015.
5.
go back to reference Muraki Y, Yagi T, Tsuji Y, Nishimura N, Tanabe M, Niwa T, et al. Japanese antimicrobial consumption surveillance: first report on oral and parenteral antimicrobial consumption in Japan (2009–2013). J Glob Antimicrob Resist. 2016;7:19–23.CrossRef Muraki Y, Yagi T, Tsuji Y, Nishimura N, Tanabe M, Niwa T, et al. Japanese antimicrobial consumption surveillance: first report on oral and parenteral antimicrobial consumption in Japan (2009–2013). J Glob Antimicrob Resist. 2016;7:19–23.CrossRef
6.
go back to reference The Government of Japan. National action plan on antimicrobial resistance (AMR) 2016–2020. 2016. The Government of Japan. National action plan on antimicrobial resistance (AMR) 2016–2020. 2016.
9.
go back to reference Goossens H, Ferech M, Goenen S, Stephens P, European Surveillance of Antimicrobial Consumption Project Group. Comparison of outpatient systemic antibacterial use in 2004 in the United States and 27 European countries. Clin Infect Dis. 2007;44:1091–5.CrossRef Goossens H, Ferech M, Goenen S, Stephens P, European Surveillance of Antimicrobial Consumption Project Group. Comparison of outpatient systemic antibacterial use in 2004 in the United States and 27 European countries. Clin Infect Dis. 2007;44:1091–5.CrossRef
10.
go back to reference Grayson ML, Crowe SM, McCarthy JS, Mills J, Mouton JW, Norrby SR, et al. Kucers’ the use of antibiotics sixth edition: a clinical review of antibacterial, antifungal and antiviral drugs. Boca Raton: CRC Press; 2010.CrossRef Grayson ML, Crowe SM, McCarthy JS, Mills J, Mouton JW, Norrby SR, et al. Kucers’ the use of antibiotics sixth edition: a clinical review of antibacterial, antifungal and antiviral drugs. Boca Raton: CRC Press; 2010.CrossRef
11.
go back to reference Hasegawa K, Yamamoto Y, Chiba N, Kobayashi R, Nagai K, Jacobs MR, et al. Diversity of ampicillin-resistance genes in Haemophilus influenzae in Japan and the United States. Microb Drug Resist. 2003;9:39–46.CrossRef Hasegawa K, Yamamoto Y, Chiba N, Kobayashi R, Nagai K, Jacobs MR, et al. Diversity of ampicillin-resistance genes in Haemophilus influenzae in Japan and the United States. Microb Drug Resist. 2003;9:39–46.CrossRef
12.
go back to reference Honda H, Sato T, Shinagawa M, Fukushima Y, Nakajima C, Suzuki Y, et al. Multiclonal expansion and high prevalence of β-lactamase-negative Haemophilus influenzae with high-level ampicillin resistance in Japan and susceptibility to quinolones. Antimicrob Agents Chemother. 2018;62:e00851-e918.CrossRef Honda H, Sato T, Shinagawa M, Fukushima Y, Nakajima C, Suzuki Y, et al. Multiclonal expansion and high prevalence of β-lactamase-negative Haemophilus influenzae with high-level ampicillin resistance in Japan and susceptibility to quinolones. Antimicrob Agents Chemother. 2018;62:e00851-e918.CrossRef
13.
go back to reference Holyfield G, Karki A. Review of prescribing by dentists in Wales. Cardiff é National Public Health Service for Wales. 2009. Holyfield G, Karki A. Review of prescribing by dentists in Wales. Cardiff é National Public Health Service for Wales. 2009.
15.
go back to reference Nair PN. Pathogenesis of apical periodontitis and the causes of endodontics failures. Crit Rev Oral Biol Med. 2004;15:348–81.CrossRef Nair PN. Pathogenesis of apical periodontitis and the causes of endodontics failures. Crit Rev Oral Biol Med. 2004;15:348–81.CrossRef
16.
go back to reference Warnke PH, Becker ST, Springer IN, Haerle F, Ullmann U, Russo PA, et al. Penicillin compared with other advanced broad spectrum antibiotics regarding antibacterial activity against oral pathogens isolated from odontogenic abscess. J Craniomaxillofac Surg. 2008;36:462–7.CrossRef Warnke PH, Becker ST, Springer IN, Haerle F, Ullmann U, Russo PA, et al. Penicillin compared with other advanced broad spectrum antibiotics regarding antibacterial activity against oral pathogens isolated from odontogenic abscess. J Craniomaxillofac Surg. 2008;36:462–7.CrossRef
17.
go back to reference Bahl R, Sandhu S, Singh K, Sahai N, Gupta M. Odontogenic infections: microbiology and management. Contemp Clin Dent. 2014;5:307–11.CrossRef Bahl R, Sandhu S, Singh K, Sahai N, Gupta M. Odontogenic infections: microbiology and management. Contemp Clin Dent. 2014;5:307–11.CrossRef
18.
go back to reference Sweeney LC, Dave J, Chambers PA, Heritage J. Antibiotic resistance in general dental practice—a cause for concern? J Antimicrob Chemother. 2004;53:567–76.CrossRef Sweeney LC, Dave J, Chambers PA, Heritage J. Antibiotic resistance in general dental practice—a cause for concern? J Antimicrob Chemother. 2004;53:567–76.CrossRef
19.
go back to reference Martins JR, Chagas OL Jr, Velasques BD, Bobrowski AN, Correa MB, Torriani MA. The use of antibiotics in odontogenic infections: What is the best choice? A systematic review. J Oral Maxillofac Surg. 2017;75(2606):e1-11. Martins JR, Chagas OL Jr, Velasques BD, Bobrowski AN, Correa MB, Torriani MA. The use of antibiotics in odontogenic infections: What is the best choice? A systematic review. J Oral Maxillofac Surg. 2017;75(2606):e1-11.
20.
go back to reference Epstein JB, Chong S, Le ND. A survey of antibiotic use in dentistry. J Am Dent Assoc. 2000;131:1600–9.CrossRef Epstein JB, Chong S, Le ND. A survey of antibiotic use in dentistry. J Am Dent Assoc. 2000;131:1600–9.CrossRef
21.
go back to reference Dar-Odeh NS, Abu-Hammad OA, Al-Omiri MK, Khraisat AS, Shehabi AA. Antibiotic prescribing practices by dentists: a review. Ther Clin Risk Manag. 2010;6:301–6.CrossRef Dar-Odeh NS, Abu-Hammad OA, Al-Omiri MK, Khraisat AS, Shehabi AA. Antibiotic prescribing practices by dentists: a review. Ther Clin Risk Manag. 2010;6:301–6.CrossRef
23.
go back to reference Ito M, Fukuda M, Suzuki Y, Wakamoto H, Ishii E. Carnitine-related hypoglycemia caused by 3 days of pivalate antibiotic therapy in a patient with severe muscular dystrophy: a case report. BMC Pediatr. 2017;17:73.CrossRef Ito M, Fukuda M, Suzuki Y, Wakamoto H, Ishii E. Carnitine-related hypoglycemia caused by 3 days of pivalate antibiotic therapy in a patient with severe muscular dystrophy: a case report. BMC Pediatr. 2017;17:73.CrossRef
24.
go back to reference Uda A, Kimura T, Nishimura S, Ebisawa K, Ohji G, Kusuki M, et al. Efficacy of educational intervention on reducing the inappropriate use of oral third-generation cephalosporins. Infection. 2019;47:1037–45.CrossRef Uda A, Kimura T, Nishimura S, Ebisawa K, Ohji G, Kusuki M, et al. Efficacy of educational intervention on reducing the inappropriate use of oral third-generation cephalosporins. Infection. 2019;47:1037–45.CrossRef
26.
go back to reference Mangram AJ, Horan TC, Pearson ML, Silver LC, Jarvis WR, Hospital Infection Control Practices Advisory Committee. Guideline for prevention of surgical site infection, 1999. Infect Cont Hosp Epidemiol. 1999;20:247–80.CrossRef Mangram AJ, Horan TC, Pearson ML, Silver LC, Jarvis WR, Hospital Infection Control Practices Advisory Committee. Guideline for prevention of surgical site infection, 1999. Infect Cont Hosp Epidemiol. 1999;20:247–80.CrossRef
27.
go back to reference Dukin MJ, Feng Q, Suda KJ, Lockhart PB, Thornhill MH, Warren K, et al. Longitudinal antibiotic prescribing trends among US dental specialists within a pharmacy benefits manager, 2013 through 2015. J Am Dent Assoc. 2019;150:846–53.CrossRef Dukin MJ, Feng Q, Suda KJ, Lockhart PB, Thornhill MH, Warren K, et al. Longitudinal antibiotic prescribing trends among US dental specialists within a pharmacy benefits manager, 2013 through 2015. J Am Dent Assoc. 2019;150:846–53.CrossRef
29.
go back to reference Pisarnturakit PP, Sooampon S, Sooampon S. Managing knowledge for health care quality: an investigation of rational antibiotic use among Thai dentists. Int J Health Plan Manag. 2020;35:606–13.CrossRef Pisarnturakit PP, Sooampon S, Sooampon S. Managing knowledge for health care quality: an investigation of rational antibiotic use among Thai dentists. Int J Health Plan Manag. 2020;35:606–13.CrossRef
30.
go back to reference Japanese association for infectious disease, Japanese society of chemotherapy; JAID, JSC committee for developing treatment guide and guidelines for clinical management of infectious disease; odontogenic infection working group. The JAID/JSC guidelines for clinical management of infectious disease-odontogenic infections. J Infect Chemother. 2016;2018(24):320–4. Japanese association for infectious disease, Japanese society of chemotherapy; JAID, JSC committee for developing treatment guide and guidelines for clinical management of infectious disease; odontogenic infection working group. The JAID/JSC guidelines for clinical management of infectious disease-odontogenic infections. J Infect Chemother. 2016;2018(24):320–4.
31.
go back to reference Landersdorfer CB, Bulitta JB, Kinzig M, Holzgrabe U, Sorgel F. Penetration of antibacterials into bone: pharmacokinetic, pharmacodynamic and bioanalytical considerations. Clin Pharmacokinet. 2009;48:89–124.CrossRef Landersdorfer CB, Bulitta JB, Kinzig M, Holzgrabe U, Sorgel F. Penetration of antibacterials into bone: pharmacokinetic, pharmacodynamic and bioanalytical considerations. Clin Pharmacokinet. 2009;48:89–124.CrossRef
32.
go back to reference Hudson JW. Osteomyelitis of the jaws: a 50-year perspective. J Oral Maxillofac Surg. 1993;51:1294–301.CrossRef Hudson JW. Osteomyelitis of the jaws: a 50-year perspective. J Oral Maxillofac Surg. 1993;51:1294–301.CrossRef
33.
go back to reference Ikeda T, Kuraguchi J, Kogashiwa Y, Yokoi H, Satomi T, Hohno N. Successful treatment of bisphosphonate-related osteonecrosis of the jaw (BRONJ) patients with sitafloxacin: new strategies for the treatment of BRONJ. Bone. 2015;73:217–22.CrossRef Ikeda T, Kuraguchi J, Kogashiwa Y, Yokoi H, Satomi T, Hohno N. Successful treatment of bisphosphonate-related osteonecrosis of the jaw (BRONJ) patients with sitafloxacin: new strategies for the treatment of BRONJ. Bone. 2015;73:217–22.CrossRef
34.
go back to reference Mehrabi M, Allen JM, Roser SM. Therapeutic agents in perioperative third molar surgical procedures. Oral Maxillofac Surg Clin N Am. 2007;19:69–84.CrossRef Mehrabi M, Allen JM, Roser SM. Therapeutic agents in perioperative third molar surgical procedures. Oral Maxillofac Surg Clin N Am. 2007;19:69–84.CrossRef
35.
go back to reference Ren YF, Malmstrom HS. Effectiveness of antibiotic prophylaxis in third molar surgery: a meta-analysis of randomized controlled clinical trials. J Oral Maxillofac Surg. 2007;65:1909–21.CrossRef Ren YF, Malmstrom HS. Effectiveness of antibiotic prophylaxis in third molar surgery: a meta-analysis of randomized controlled clinical trials. J Oral Maxillofac Surg. 2007;65:1909–21.CrossRef
36.
go back to reference Alanis A, Weinstein AJ. Adverse reactions associate with the use of oral penicillins and cephalosporins. Med Clin N Am. 1983;67:113–29.CrossRef Alanis A, Weinstein AJ. Adverse reactions associate with the use of oral penicillins and cephalosporins. Med Clin N Am. 1983;67:113–29.CrossRef
37.
go back to reference Thornhill MH, Dayer MJ, Durkin MJ, Lockhart PB, Baddour LM. Risk of adverse reactions to oral antibiotics prescribed by dentists. J Dent Res. 2019;98:1081–7.CrossRef Thornhill MH, Dayer MJ, Durkin MJ, Lockhart PB, Baddour LM. Risk of adverse reactions to oral antibiotics prescribed by dentists. J Dent Res. 2019;98:1081–7.CrossRef
Metadata
Title
Effect of educational intervention on the appropriate use of oral antimicrobials in oral and maxillofacial surgery: a retrospective secondary data analysis
Authors
Junya Kusumoto
Atsushi Uda
Takeshi Kimura
Shungo Furudoi
Ryosuke Yoshii
Megumi Matsumura
Takayuki Miyara
Masaya Akashi
Publication date
01-12-2021
Publisher
BioMed Central
Published in
BMC Oral Health / Issue 1/2021
Electronic ISSN: 1472-6831
DOI
https://doi.org/10.1186/s12903-020-01367-1

Other articles of this Issue 1/2021

BMC Oral Health 1/2021 Go to the issue